Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Zimmer Holdings, Inc. : Zimmer Receives FDA Warning on Certain Hip Implants

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/02/2012 | 12:40am CET

--Zimmer says FDA inspection of Puerto Rico plant turned up concerns about manufacturing of certain implants

--FDA in letter noted manufacturing, testing issues related to Trilogy Acetabuar System products, company says

--Zimmer says it is notifying customers of manufacturing issue, but hasn't withdrawn any products

(Adds context on metallic spikes in fourth paragraph and a no comment from Zimmer in seventh paragraph.)

 
   By Kristin Jones 
 

Zimmer Holdings Inc. (ZMH) said a U.S. Food and Drug Administration inspection of its plant in Puerto Rico turned up concerns about the manufacturing of certain hip implants.

The orthopedic maker's Zimmer Inc. subsidiary received a warning letter from the FDA dated Sept. 19, the company said in a regulatory filing Monday. In the letter, the FDA noted manufacturing and testing issues related to the company's Trilogy Acetabular System products, which are implanted in hip-replacement surgery.

Specifically, the U.S. drug regulator noted that Zimmer hadn't implemented a testing mechanism to show that its products met design specifications. The company also hadn't validated the effect of certain manufacturing operations on Trilogy products that incorporate metallic spikes.

Spikes are used to connect the hip replacement cup to a patient's bone when cement and screws are deemed insufficient.

The FDA requires that drug and medical-device makers undertake steps to ensure the quality of the design and manufacture of its products, known as process validation.

Zimmer said it is notifying customers of the manufacturing issue, but that it hasn't withdrawn any products. The company also said it previously suspended release of the spiked products, pending validation of the processes cited in the letter, and expects to complete validation in the next few weeks.

A Zimmer spokesman declined to comment further.

Shares gained 11 cents to $67.98 in after-hours trading. Through Monday's close, the stock was up 27% so far this year.

--Joseph Walker contributed to this article.

Write to Kristin Jones at kristin.jones@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ZIMMER BIOMET HOLDINGS INC
03/23 ZIMMER BIOMET HOLDINGS, INC. (NYSE : ZBH) Files An 8-K Departure of Directors or..
03/23 ZIMMER BIOMET HOLDINGS, INC. : Change in Directors or Principal Officers (form 8..
03/21 INSIDER TRADING ACTIVITY ZIMMER BIOM : ZBH) – Insider Sold 1,040 shares of..
03/21 SMITH & NEPHEW : Hip and Knee Orthopedic Surgical Robots Market 2017 - Stryker/M..
03/14 ZIMMER BIOMET : Mar 14, 2017 Zimmer Biomet Showcases New Product Innovation, Nov..
03/04 ZIMMER BIOMET : Today the Zimmer Biomet Holdings, Inc. Position Boosted by Winsl..
03/01 ZIMMER BIOMET : Management's Discussion and Analysis of Financial Condition and ..
02/24 ZIMMER BIOMET : Feb 24, 2017 Zimmer Biomet Holdings to Present at the Cowen and ..
02/16 ZIMMER BIOMET : Announces the International Release of the Innovative Subchondro..
02/10 ZIMMER BIOMET : slicing 1% of its US jobs Warsaw company mum on actual number to..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
03/22DJMEDTRONIC : Files 8K - Other Events
03/17DJMEDTRONIC : Less-Invasive Treatment Yielded Similar Outcome as Open-Heart Surger..
03/11DJLUXOTTICA : Smart Glasses Get a Fresh Look -- WSJ
03/09DJLUXOTTICA : Eyewear Makers Take a Fresh Look at Smart Glasses
03/09DJLUXOTTICA : Eyewear Makers Rethink Smart Glasses
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
03/21 Northcoast upgrades Wright Medical to Buy amidst takeover speculation at ~$36
03/01 Zimmer Biomet declares $0.24 dividend
02/23 Back To The Future With Wright Medical
02/13 DIVIDEND CHALLENGERS (AND NEAR-CHALL : 87 Increases Expected By April 30
02/09 VALUATION DASHBOARD : Healthcare - Update
Advertisement
Financials ($)
Sales 2017 7 886 M
EBIT 2017 2 584 M
Net income 2017 1 165 M
Debt 2017 9 251 M
Yield 2017 0,80%
P/E ratio 2017 24,07
P/E ratio 2018 17,67
EV / Sales 2017 4,27x
EV / Sales 2018 4,00x
Capitalization 24 410 M
More Financials
Chart ZIMMER BIOMET HOLDINGS INC
Duration : Period :
Zimmer Biomet Holdings Inc Technical Analysis Chart | ZBH | US98956P1021 | 4-Traders
Full-screen chart
Technical analysis trends ZIMMER BIOMET HOL...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 135 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David C. Dvorak President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Daniel P. Florin Chief Financial Officer & Senior Vice President
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
Arthur Joseph Higgins Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS..17.62%24 410
MEDTRONIC PLC13.72%110 880
BAXTER INTERNATIONAL I..16.80%28 068
HOYA CORPORATION9.69%18 912
C R BARD INC11.09%18 047
DENTSPLY SIRONA INC8.52%14 390
More Results